öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

Áõ×涴µÄÒÅ´«Ñ§£¨µÚ¶þ°æ£©±Ê¼Ç
ÒÅ´«Ñ§×ܸ´Ï°
µÚÒ»Õ  Ð÷ÂÛ
       ÒÅ´«Ñ§¼°·Ö֧ѧ¿Æ
ÒÅ´«Ñ§µÄ·¢Õ¹¡¢ÈÎÎñ
µÚ¶þÕ  Ãϵ¶û¶¨ÂÉ
key¡¡words£º
  ·´Ó¦¹æ·¶£¨reaction  norm£©¡¢µÈλ»ùÒò£¨allele£©¡¢¸´µÈλ»ùÒò£¨multiple  alleles£©¡¢ ±íÐÍģд£¨phenocopy£©¡¢ÍâÏÖÂÊ£¨penetrance£© ¡¢»¥²¹»ùÒò£¨complementary gene£©¡¢ ÒÖÖÆ»ùÒò£¨suppress  gene£©¡¢±íÏֶȣ¨expressivity£©¡¢ÒÖÖÆ»ùÒò£¨inhibitor£©¡¢ÉÏλЧӦ£¨epistatic effect £©¡¢µþ¼ÓЧӦ(duplicate effect)
Ò»¡¢»ý¼Ó¸ÅÂÊ  ¿¨Æ½·½²âÑé  Èý´ó¶¨ÂÉ  ϵÆ×·ûºÅ  ¸ÅÂʵÄÓ¦Óà
¶þ¡¢ÒÅ´«µÄȾɫÌåѧ˵
Èý¡¢Ï¸°û·ÖÁÑÖÐȾɫÌåµÄ±ä»¯  ºËÐÍ  ȾɫÌåÐÎ̬·ÖÎö
ËÄ¡¢»ùÒòµÄ×÷Óü°Óë»·¾³µÄ¹Øϵ
Îå¡¢»ùÒòÓë»·¾³
Áù¡¢Ò»Òò¶àЧ¡¢¶àÒòһЧ
Æß¡¢ÏÔ¡¢ÒþÐÔµÄÏà¶ÔÐÔ
°Ë¡¢ÖÂËÀ»ùÒò
¾Å¡¢ABOѪÐÍ¡¢RhѪÐÍ¡¢HLAѪÐÍ¡¢ÑªÐͲ»Ç׺Í¡¢ÃÏÂòÐÍÓëÀàÃÏÂòÐÍ
Ê®¡¢·ÇµÈλ»ùÒò¼äµÄ×÷Ó㺻¥²¹¡¢ÒÖÖÆ¡¢ÏÔÐÔÉÏλ¡¢ÒþÐÔÉÏλ
µÚÈýÕ ¡¡Á¬ËøÒÅ´«·ÖÎöÓëȾɫÌå×÷ͼ 
key  word£º
  °éÐÔÒÅ´«£¨sex-linked  inheritance£©¡¢´ÓÐÔÒÅ´«£¨sex-condition  inheritance£©¡¢ 
  ÏÞÐÛÒÅ´«£¨holandric  inheritance£©¡¢»ùÒò×éÓ¡¼££¨genomic  imprinting£©¡¢
  Lyon ¼Ù˵¡¢ ¶¯Ì¬Í»±ä£¨dynamic  mutation£©¡¢ÄⳣȾɫÌå»ùÒò£¨pseudoautosomal  gene£©¡¢ÐÔ·Ö»¯£¨sex  differentiation£©¡¢  ´àÐÔX×ÛºÏÖ¢£¨fragile X  syndrome £©¡¢ØºÍè¾ö¶¨Òò×Ó£¨testis-determining  factor £©
Ò»¡¢ÐÔ±ð¾ö¶¨Óë°éÐÔÒÅ´«
1¡¢ ÐÔ±ð¾ö¶¨£º
1£©¡¢È¾É«ÌåµÄÐÔ¾ö¶¨£ºXYÐÍ¡¢ZWÐÍ¡¢XOÐÍ
2£©¡¢ÆäËû£ºµ¥±¶ÐÍ¡¢»·¾³¾ö¶¨¡¢»ùÒò¾ö¶¨
2¡¢»·¾³¶ÔÐÔ·Ö»¯µÄÓ°Ï죺
1£©¡¢Íâ»·¾³£ºÓªÑø¡¢Î¶È¡¢¹âÕÕµÈ
2£©¡¢ÄÚ»·¾³£º¼¤ËØ
3¡¢ÈËÀàÐÔ±ð»ûÐΣº
1£©¡¢ÐÔȾɫÌåÊýÄ¿¸Ä±ä£º
   £¨1£©¡¢ÏÈÌìÐÔغÍè·¢Óý²»È«£¨Klinefelter  syndrome£©£º47£¬XXY
   £¨2£©¡¢ÐÔÏÙ·¢Óý²»È«£¨Turner  syndrome£©£º45£¬XO
   £¨3£©¡¢¶àXÓë¶àY¸öÌå
   £¨4£©¡¢ÕæÁ½ÐÔ»ûÐΣº46£¬XX/47£¬  XXY¡¢46£¬XY/XO¡¢46£¬XX/46£¬XYµÈ
   2£©¡¢ÐÔȾɫÌå½á¹¹µÄ¸Ä±ä£º
       £¨1£©¡¢´àÐÔXȾɫÌ岡£¨fragile  X  syndrome£©£º¶¯Ì¬Í»±ä
       £¨2£©¡¢YȾɫ¶Ì±Ûȱʧ
   3£©¡¢»ùÒòÍ»±ä£º     
     £¨1£©¡¢ÄÐÐÔÒõÑôÈË£¨ÄмÙÁ½ÐÔ»ûÐΣ©£º46£¬XY
         XȾɫÌåÉÏÐÛÐÔ¼¤ËØÊÜÌå»ùÒò£¨tfm£©»ò³£È¾É«ÌåÃæ5¦Á-»¹Ô­Ã¸     
      »ùÒòÍ»±ä¡£
       £¨2£©¡¢Å®ÐÔÒõÑôÈË£¨¼ÙÁ½ÐÔ»ûÐΣ©£º46£¬XX
            21ôÇ»¯Ã¸»ò11¦Â-ôÇ»¯Ã¸»ùÒòÍ»±ä£¬µ¼ÖÂÐÛÐÔ¼¤ËزúÉú ¡£
4£©¡¢ÐÔ»ûÐεÄÔ­Òò£º
      ÊÇÓÉÓÚÇ×ÌåµÄÉúֳϸ°ûÔÚ¼õÊý·ÖÁÑÖУ¬ÐÔȾɫÌå²»·ÖÀë»òË«Êܾ«ÒýÆð¡£
4¡¢ÐÔ±ð¼ì²â£ºÈ¾É«Ìå·¨¡¢È¾É«ÖÊ·¨¡¢·Ö×ÓÔÓ½»·¨¡¢PCR·¨
5¡¢°éÐÔÒÅ´«£º
1£©¡¢°éÐÔÒÅ´«µÄÌص㣺ÓëÐÔ±ðÓйØ£¬ÃÏʽÒÅ´«£¬Õý·´½»½á¹û²»Í¬
2£©¡¢ÈËÀ༸ÖÖ°éÐÔÒÅ´«µÄÐÔ×´£ºÑªÓѲ¡¡¢É«Ã¤¡¢XgѪÐÍ¡¢Íº¶¥¡¢HDÎ赸֢¡¢DM¼¡ÓªÑø²»Á¼µÈ
       ¶þ¡¢ ȾɫÌåºÍÁ¬ËøȺ
  key  words£ºÁ¬Ëø¡¢µ¥½»»»(single crossingover)¡¢Ë«½»»»£¨double crossingover£©¡¢½»»»ÂÊ (crossing frequency)¡¢    ÖØ×éÂÊ(recombinant frequency)¡¢ ͼ¾à(map distance)
£¨Ò»£©Á¬ËøÓë½»»»£ºÍêÈ«Á¬Ëø¡¢²»ÍêÈ«Á¬Ëø
£¨¶þ£©Èýµã²âÑé
£¨Èý£©½»»»ÖµÓëÖØ×éÖµ
£¨ËÄ£©·¢ÂÊÓë¸ÉÉ棺¸ÉÉæ=1-²¢·¢ÂÊ
£¨Î壩Õæ¾úÀàµÄÒÅ´«·ÖÎö
µÚËÄÕ  »ùÒòÓë»ùÒò×é
key  words£º
ëò¡¶¾£¨prion£©¡¢ºËø£¨ribozyme£©¡¢ÈÎÒâÒýÎïPCR(arbitrarily  primed  PCR  AP-PCR)¡¢Southern  blot ¡¢Northern  blot¡¢Western blot¡¢Ô­Î»ÔÓ½»£¨in  situ  hybridization£©¡¢HGP£¨Human  Genome  Program£©¡¢¾ÛºÏøÁ´Ê½·´Ó¦£¨ polymerase  chain  reaction£¬PCR£©¡¢ÏÞÖÆÐÔƬ¶Ï³¤¶È¶à̬ÐÔ(reaction  length  polymorphism£¬RFLP)¡¢¡¢»ùÒò¼Ò×壨gene families£©¡¢»ùÒò´Ø(gene cluster)¡¢»ùÒò¶ªÊ§£¨gene elimination£©¡¢»ùÒòÀ©Ôö£¨gene amplification£©¡¢»ùÒòÖØÅÅ (gene rearrangement)¡¢(AFLP£¨amplified  fragments length polymorphism£©)
Ò»¡¢ ÒÅ´«µÄ·Ö×Ó»ù´¡
1¡¢ Prion
2¡¢ ºËø
¶þ¡¢ »ùÒòµÄ±¾ÖÊ
1¡¢ »ùÒòµÄ¸ÅÄî
2¡¢ (CotÇúÏßÓëÖظ´Ë³Ðò)
Èý¡¢ »ùÒò×é
1¡¢ Ô­ºËÉúÎï»ùÒò×éÌصã
2¡¢ ÕæºËÉúÎï»ùÒò×éÌصã
3¡¢ ·Ö×ÓÔÓ½»
4¡¢ PCR(polymerase chain reaction)¼¼Êõ
5¡¢ ¼¸ÖÖÌØÊâµÄPCR
6¡¢ »ùÒòµÄ²î±ðÏÔʾԭÀí
7¡¢ RFLP(restriction fragment length polymorphism)£­ÏÞÖÆÐÔƬ¶Î³¤¶È¶à̬
8¡¢ »ùÒò¶¨Î»£¨gene  mapping£©
9¡¢ÈËÀà»ùÒò×é¼Æ»®
µÚÎåÕ¡¡¡¡Ï¸¾úºÍÊɾúÌåµÄÖØ×éÓëÁ¬Ëø
key  words£º½ÓºÏ£¨conjugation£©¡¢×ª»¯£¨transformation£©¡¢×ªµ¼£¨transduction£©¡¢ÐÔµ¼£¨sexduction£©¡¢×ªÈ¾£¨transfection£©¡¢ºÏ×ÓÓÕµ¼£¨zygotic  induction£©¡¢
   1¡¢F+ ¡ÁF¡¥ ¡úF+ 
     2¡¢Hfr ¡ÁF¡¥¡úF¡¥
   3¡¢F¡ä ¡ÁF¡¥ ¡úF+
   4¡¢Ï¸¾úµÄÁ¬Ëø·ÖÎö£º
        1£©¡¢ÖжÏÔÓ½»